Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERATOR: Cognitive Outcomes in Renal Transplant Patients Switched to Envarsus XR
NCT04838288Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jun 2021
- Primary completion
- Jan 2025
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by Vanderbilt University Medical Center. Started Jun 2021; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT04838288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838288.